These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 11781710)

  • 1. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
    Vockerodt M; Tesch H; Kube D
    Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway.
    Vockerodt M; Haier B; Buttgereit P; Tesch H; Kube D
    Virology; 2001 Feb; 280(2):183-98. PubMed ID: 11162833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A; Arena G; Stecca C; Raciti M; Mattia E
    Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of IκB-ζ by Epstein-Barr virus latent membrane protein-1 and CD30.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2015 Dec; 47(6):2197-207. PubMed ID: 26498461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells.
    Pai S; O'Sullivan BJ; Cooper L; Thomas R; Khanna R
    J Virol; 2002 Feb; 76(4):1914-21. PubMed ID: 11799186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
    Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
    Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a.
    Motsch N; Pfuhl T; Mrazek J; Barth S; Grässer FA
    RNA Biol; 2007 Nov; 4(3):131-7. PubMed ID: 18347435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
    Liebowitz D
    N Engl J Med; 1998 May; 338(20):1413-21. PubMed ID: 9580648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
    Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
    Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.
    Nakagomi H; Dolcetti R; Bejarano MT; Pisa P; Kiessling R; Masucci MG
    Int J Cancer; 1994 Apr; 57(2):240-4. PubMed ID: 8157362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
    Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
    Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination.
    Walter J; Schirrmacher V; Mosier D
    Int J Cancer; 1995 May; 61(3):363-9. PubMed ID: 7537255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB only partially mediates Epstein-Barr virus latent membrane protein 1 activation of B cells.
    Liljeholm S; Hughes K; Grundström T; Brodin P
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2117-25. PubMed ID: 9747720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.
    Siegler G; Kremmer E; Gonnella R; Niedobitek G
    Mol Pathol; 2003 Jun; 56(3):156-61. PubMed ID: 12782762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the Epstein-Barr virus protein LMP1 mediates tumor regression in vivo.
    Cherney BW; Sgadari C; Kanegane C; Wang F; Tosato G
    Blood; 1998 Apr; 91(7):2491-500. PubMed ID: 9516150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.
    D'Souza BN; Edelstein LC; Pegman PM; Smith SM; Loughran ST; Clarke A; Mehl A; Rowe M; Gélinas C; Walls D
    J Virol; 2004 Feb; 78(4):1800-16. PubMed ID: 14747545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
    Robertson KD; Manns A; Swinnen LJ; Zong JC; Gulley ML; Ambinder RF
    Blood; 1996 Oct; 88(8):3129-36. PubMed ID: 8874213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
    Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
    Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.